Onex Canada Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-103,681
Closed -$25.2M 78
2017
Q2
$25.2M Buy
103,681
+38,683
+60% +$9.09M 2.31% 18
2017
Q1
$15.5M Sell
64,998
-37,918
-37% -$8.83M 1.36% 30
2016
Q4
$21.6M Sell
102,916
-1,795
-2% -$372K 1.9% 24
2016
Q3
$23.6M Sell
104,711
-2,845
-3% -$695K 2.23% 20
2016
Q2
$24.9M Sell
107,556
-2,111
-2% -$487K 2.15% 17
2016
Q1
$29.4M Sell
109,667
-1,904
-2% -$545K 2.63% 15
2015
Q4
$34.9M Sell
111,571
-115,653
-51% -$34.4M 2.53% 15
2015
Q3
$46.1M Sell
227,224
-52,690
-19% -$16.2M 4.45% 7
2015
Q2
$106M Sell
279,914
-16,017
-5% -$4.78M 5.49% 3
2015
Q1
$88.1M Buy
+295,931
New +$84.4M 5.59% 3

Other funds holding AGN

Onex Canada Asset Management's AGN Position: Q3 2017 in Review

Onex Canada Asset Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 103,681 shares — an estimated $25.2M sold.

Onex Canada Asset Management first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $106M in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Onex Canada Asset Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Onex Canada Asset Management sold 103,681 Allergan plc shares in Q3 2017, an estimated $25.2M.
  • Onex Canada Asset Management first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
  • Onex Canada Asset Management's Allergan plc position peaked at $106M in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Onex Canada Asset Management's 13F filing for Q3 2017, filed 1 Nov 2017.